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Abstract The aim of the study was to analyse the out-
comes of children born with oesophageal atresia over the
last 3 decades. The records of 104 patients born between
1973 and 1999 were reviewed retrospectively. To evalu-
ate changes over time, the analysis was done for three
consecutive time periods: 1973–79, 1980–89, and 1990–
99. Mean birth weight was 2553 g (SD 640), and mean
gestational age was 39 weeks (SD 4). Forty-two new-
borns (40%) had one or more associated congenital
malformations, and 30% had associated cardiac mal-
formations. There was no change in incidence of asso-
ciated anomalies over the three time periods studied.
Mortality of patients decreased from 33% to 14%
(p =0.048). There was a signiﬁcant association between
the presence of a major cardiac malformation and sur-
vival (survival: 88% vs. 57%, p =0.004). Analysing the
three diﬀerent time periods separately reveals that car-
diac disease was not a signiﬁcant risk factor in the ﬁrst
period but became signiﬁcant in the period from 1980–
99 (relative risk: 6.76, 95% CI 1.44–31.77). Birth weight
was signiﬁcantly higher in infants who survived (2626 g,
SD 642) compared with those who died (2290,
SD 570, p = 0.028). This eﬀect, however, is mainly
based on the diﬀerence during the ﬁrst period and is lost
later. Early and late postoperative complications oc-
curred in 44/102 patients. Strictures developed in 33/91
patients who survived the ﬁrst month of life (33%). The
rate of symptomatic strictures decreased signiﬁcantly
over the three time periods, from 50% to 23%
(p=0.022). In summary, this study shows no signiﬁcant
change in patient characteristics over the last 3 decades,
but mortality and postoperative complication rates de-
creased, and associated cardiac anomalies became the
far most important risk factor for mortality.
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Introduction
Since the ﬁrst correction of an oesophageal atresia more
than 50 years ago, many things have changed in regard
to treatment and outcome. Over the decades, the overall
survival rate has steadily improved because of advances
in surgical techniques and in preoperative and postop-
erative medical care [5,8]. In addition, some studies also
showed a change in patient characteristics [3,4]. The
purposes of this study were to review these changes in
characteristics and management of patients born with
oesophageal atresia and the impact of these changes on
mortality and postoperative results. To do this, we
analysed the data from a series of infants with oesoph-
ageal atresia treated in our institution since 1973.
Patients and methods
The case records of all infants with oesophageal atresia
and/or tracheo-oesophageal ﬁstula admitted to the
University Children’s Hospital in Bern between
November 1973 and December 1999 were reviewed.
Data recorded included birth weight, duration of preg-
nancy, presence of cardiac defects and other associated
anomalies (VACTERL association), surgical interven-
tions, complications, and outcome. A major cardiac
anomaly was deﬁned as either cyanotic congenital heart
disease that required surgery or noncyanotic congenital
heart disease that required medical or surgical treatment
for cardiac failure. This deﬁnition excluded patent duc-
tus arteriosus unless it required surgical ligation. A
diagnosis of VACTERL syndrome was made if three or
more components of the association were present.
To critically evaluate changes over time, the patients
were analysed over three consecutive time periods: 1973–
1979, 1980–1989, and 1990–1999. Statistical analysis was
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performed using a commercial statistics package (Stat-
View 4.0, Abacus Concepts, Berkeley, CA, USA). For
continuous data, diﬀerences between groups were as-
sessed using an unpaired student’s t-test or one-way
analysis of variance (ANOVA). Chi-square analysis was
employed for categorical data. Instead of odds ratio,
relative risk was calculated because the outcome of
interest was not considered rare. Diﬀerences were con-
sidered signiﬁcant at a probability level of p <0.05.
Results
Patient characteristics
During the 27-year period, 104 patients were treated for
oesophageal atresia. Mean followup was 12 years (SD
9). The mean birth weight was 2553 g (SD 640), and
seven patients (7%) had a birth weight <1500 g. The
mean gestational age was 39 weeks (SD 4), with 28 pa-
tients (27%) having a gestational age <37 weeks. Ta-
ble 1 shows the distribution of the types of atresia. Over
the three time periods, mean birth weight or mean ges-
tational age did not change signiﬁcantly (Table 2).
Comorbidity
Forty-two newborns (40%) had one or more associated
congenital malformations: vertebral malforation in 11
patients, anorectal in ﬁve, cardiac in 30, renal in 10, limb
in four, duodenal atresia in two, and chromosomal
abnormalities in seven. There was no increase in asso-
ciated malformations over the observed time period. The
percentage of associated cardiac malformations was
30% and remained stable as well (Table 2). A VACT-
ERL association was diagnosed in 13/104 patients
(13%).
Operations
Simple ﬁstula ligation was performed in all four children
with an H-type ﬁstula. A primary anastomosis was
performed in 84/94 (91%) patients with atresia and ﬁs-
tula, a delayed primary repair in three (3%) patients,
and a staged repair in four (4%) patients. Two patients
with trisomy 18 did not undergo operation, and in one
patient with a massive intracerebral haemorrhage, only a
gastrostomy was performed. Six neonates had pure
oesophageal atresia without tracheo-oesophageal ﬁstula.
Of these, ﬁve patients underwent colonic interposition,
and one patient had gastric transposition. In regard to
operative management, there were no gross changes
during the observed 3 decades.
Outcome
Overall mortality was 22% (22/104). Mortality de-
creased signiﬁcantly from 31% in period 1, between
1973 and 1979, to 14% in period 2, and remained stable
thereafter (Table 3). There was a signiﬁcant association
between the presence of a major cardiac malformation
and survival (survival without vs. with cardiac malfor-
mations: 88% vs. 57%, p =0.004) but not with the
presence of VACTERL syndrome and survival (p
=0.36). The relative mortality risk for major cardiac
disease was 3.57 (95% CI 1.69–7.5). Analysing the three
diﬀerent time periods separately reveals that cardiac
disease was not a signiﬁcant risk factor in the period
from 1973–1979 (relative risk: 2.63, 95% CI 0.24–6.13),
whereas the relative mortality risk for major cardiac
malformations was signiﬁcantly increased in the period
from 1980–1999 (6.76, 95% CI 1.44–31.77). This ﬁnding
reﬂects the fact that in the 1970s, death in the neonatal
period was very often related to respiratory failure,
sepsis/multiorgan failure, or both (7/13 neonates who
died), in contrast to the period from 1980–1999, when no
neonate in this study died due to these sorts of problems.
From 1980–1999, 2/9 deaths occurred owing to trisomy
18 (no operation), one to massive perinatal ventricular
haemorrhage, and one to sudden infant death (trisomy
21). All others were associated with major cardiac
Table 1 Types of atresia in 104 patients from 1973–1999 (OA
oesophageal atresia, TOF tracheo-oesophageal ﬁstula)
Type 1973–1979 1980–1989 1990–1999 Total
n (%) n (%) n (%) n (%)
OA and distal TOF 34 (87) 27 (93) 25 (70) 86 (86)
OA and proximal TOF – – 2 (6) 2 (2)
OA and proximal
and distal TOF
2 (5) 1 (3) 3 (8) 6 (6)
OA without TOF 1 (3) 1 (3) 4 (11) 6 (6)
H-type TOF 2 (5) – 2 (6) 4 (4)
Table 2 Patient characteristics
Variable 1973–1979 (n =39) 1980–1989 (n =29) 1990–1999 (n =36) All patients (n =104) p
n (SD or %) n (SD or %) n (SD or %) n (SD or %) 1973–1979 vs.
1990–1999
Gestational age 39 (4) 39 (3) 38 (4) 39 (4) 0.648
Birth weight 2590 (597) 2688 (577) 2409 (715) 2553 (640) 0.24
Associated anomalies 15 (38%) 14 (48%) 13 (36%) 42 (40%) 0.94
Major cardiac defects 12 (31%) 7 (24%) 11 (31%) 30 (29%) 0.98
Chromosomal abnormalities 2 (5%) 2 (7%) 3 (8%) 7 (7%) 0.66
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anomalies; in 2/5, the anomalies were in combination
with trisomy 21.
Birth weight was signiﬁcantly higher in infants who
survived (2626 g, SD 642) compared with those who
died (2290, SD 570, p =0.028). This eﬀect, however, is
mainly based on the diﬀerence during the period from
1973–1979 (2732 g, SD 577, vs. 2327, SD 562, p=0.047,
mean diﬀerence 404 g), analysing the last period be-
tween 1990 and 1999 separately, the diﬀerence did not
reach signiﬁcance (2452 g, SD 706, vs. 2142 g, SD 794,
p = 0.15, mean diﬀerence 310 g). Overall, gestational
age was signiﬁcantly greater in infants who survived
compared with those who died (39 weeks, SD 3, vs. 37
weeks, SD 4, p=0.035). From 1990–1999, however, the
diﬀerence was not signiﬁcant (38 weeks, SD 4, vs. 37
weeks, SD 5, p =0.60).
Outcomes of children between 1980 and 1999 with
respect to Spitz’s classiﬁcation are shown in Table 4.
The three patients in group 1 died of trisomy 18, massive
perinatal ventricular haemorrhage, and sudden infant
death at the age of 3 months.
Early and late postoperative complications occurred
in 44/102 patients (Table 3). An anastomotic leak
(symptomatic or observed on routine postoperative
oesophagography) was reported in seven patients (7%).
Two of these patients developed a recurrent ﬁstula that
required a second intervention. The incidence of anas-
tomotic leaks did not change over time. Spontaneous
resolution of the leak was observed in 5/7 patients.
There were no strictures as a consequence of an anas-
tomotic leak. Recurrent ﬁstulas developed in a total of
seven patients (7%), with a relevant decrease in inci-
dence over the last decades. Strictures occurred in 33/91
patients who survived the ﬁrst month of life (33%). The
strictures were successfully treated by dilatations in all
but two patients, in whom a resection of the stricture
was necessary. Strictures resolved after one or two dil-
atations in 19 patients (58%); in 14 patients more than
two sessions were needed. The mean number of dilata-
tions performed was 3.6 (range 1–14) per patient. The
number of patients who had to undergo dilatations be-
cause of strictures decreased signiﬁcantly over the three
time periods, from 50% to 23% (Table 3). Either a
primary or secondary Nissen fundoplication was per-
formed in 20 patients (20%; primary, 7; secondary, 13).
A re-do fundoplication was necessary in one patient. No
aortopexy was performed.
Comment
The mortality of patients studied decreased from 33% to
14% since 1973. In recent years there was a strong
association between mortality and major cardiac
anomalies. Postoperative complications such as stricture
formation and recurrent tracheo-oesophageal ﬁstulas
decreased signiﬁcantly over the studied time period. The
percentage of children born with associated anomalies
did not change over time.
Several risk factors are well established for adverse
outcome after correction for oesophageal atresia,
including birth weight and the presence of associated
anomalies [11, 12, 13]. There is some evidence that the
risk proﬁle of children born with oesophageal atresia
(that is, the expression or incidence of these risk factors)
has changed over time. Deruloo et al. reported a de-
crease in mean gestational age and birth weight of pa-
tients born with oesophageal atresia over the last 5
decades [3]. In addition, they reported an increased rate
of associated anomalies, a ﬁnding conﬁrmed by Driver
et al. [4]. Our patients treated nowadays are born earlier
and weigh less than those treated 30 years ago, too;
however, the diﬀerence did not reach signiﬁcance. This
might be due to the smaller number of patients. But
in contrast to the previously mentioned studies [3, 4],
we found no increase in the frequency of associated
Table 4 Survival related to
birth weight (BW ) and major
congenital heart disease (CHD)
(1980–1999, n =65)
Group n Mortality Survival rate (%)
I BW >= 1500 g and no major CHD 44 3 93
II BW <1500 g or major CHD 19 5 74
III BW <1500 g and major CHD 2 1 50
Table 3 Outcomes 1973–1999 (TOF tracheo-oesophageal ﬁstula)
Variable 1973–1979 (n =39) 1980–1989 (n =29) 1990–1999 (n =36) Total (n =104) p
n (%) n (%) n (%) n (%) 1973–1979 vs.
1990–1999
Mortality 13 (33%) 4 (14%) 5 (14%) 22 (22%) 0.048
Anastomotic leak 2 (5%) 2 (7%) 3 (8%) 7 (7%) 0.57
Stricture requiring dilatationa 15/30 (50%) 10/26 (38%) 8/35 (23%) 33/91 (36%) 0.022
No. dilatations per patient
(range)
3.5 (1–9) 3.6 (1–9) 3.8 (1–14) 3.6 (1–14) 0.87
Recurrent TOF 5 (17%) 1 (4%) 1 (3%) 7 (7%) 0.055
Fundoplication 10 (26%) 5 (17%) 5 (14%) 20 (19%) 0.41
aPatients surviving the 1st month of life
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malformations over the last 3 decades in our population.
The percentage of children with any type of associated
malformation, as well as the percentage of children with
cardiac defect as the only associated malformation, did
not change over the observed period. Therefore, we can
assume that the risk proﬁle of the patients treated today
is not much diﬀerent from that of the patients treated at
the beginning of the study period.
In regard to mortality, two things changed. First, as
reported by other authors [3, 5, 8, 10, 11], mortality
decreased drastically. Second, there is some evidence
that the predictors for adverse outcome changed, with
cardiac anomalies becoming the most important risk
factor [2, 3, 7, 11]. This change seems to be mainly due to
improved preoperative and postoperative care. Between
1973 and 1979, more than half of the patients died in the
ﬁrst 30 days of life due to respiratory failure, sepsis/
multiorgan failure, or both. Since that time, only one
patient who underwent corrective surgery died during
the neonatal period, in this case as a consequence of
major cardiac defects. Improvements in neonatal inten-
sive care have contributed to an increased survival rate
of even very premature, high-risk infants, thereby
attenuating the inﬂuence of gestational age and birth
weight on outcome. In our study population, the mean
diﬀerences in birth weight and gestational age between
neonates who survived and those who did not decreased
from 404 g and 1.6 weeks in the ﬁrst period to 310 g and
1 week in the last period. The fact that birth weight
might not be a powerful predictor is underlined by
ﬁndings of a large recent study that did not show a
diﬀerence in survival in patients with birth weights
<1500 g when compared with patients with birth
weights >1500 g [2]. In the Montreal experience, birth
weight did not aﬀect survival, either [12].
The relevance of associated cardiac malformations as
a risk factor for mortality, however, gained more and
more importance in our study population over the years.
This observation is in accordance with several other
reports [2, 3, 7] and was one of the reasons for Spitz
et al. to propose a new classiﬁcation for predicting
outcome [11]. In the 1970s, associated cardiac anomalies
were not a signiﬁcant risk factor for mortality, whereas
from 1990–1999, the relative mortality risk was more
than six times higher in patients with associated cardiac
disease. In the last decade, death was associated with
major cardiac defects in all but one patient, who had
trisomy 18. Other associated malformations such as the
VACTERL association had no impact on mortality. Of
interest is the fact that none of the patients with trisomy
21 survived. Although the small number of patients with
Down syndrome precludes deﬁnite conclusions, it might
indicate that outcomes in children with associated tri-
somy 21 are diﬀerent from those without trisomy 21, a
ﬁnding also observed by others [1, 2].
Not only improvements in intensive care manage-
ment but also improvements in surgical skills led to a
signiﬁcant decrease in postoperative complications in the
study patients over the last 3 decades. Whether this is
due to a more delicate tissue handling, to improved su-
ture material, or to other surgical factors cannot be
established. In any case, the incidence of recurrent ﬁstula
formation and the formation of symptomatic strictures
necessitating dilatations decreased signiﬁcantly. In the
1970s, 50% of patients needed one or more dilatations
because of anastomotic stricture formation, compared
with only 23% in the last decade. The mean number of
dilatations per patient remained unchanged. In more
than half of the patients, strictures resolved after one or
two dilatations. The low incidence of stricture formation
and the fact that more than half of the patients needed
not more than one or two dilatations may call into
question the usefulness of routine dilatations after
oesophageal atresia repair, an observation conﬁrmed by
a recent study [6]. For unknown reasons, the number of
anastomotic leaks did not change and remained between
5% and 8% in the three periods observed. As reported
elsewhere, there was no association between anasto-
motic leaks and stricture formation [9]. None of our
patients with an anastomotic leak developed a symp-
tomatic stricture on followup.
In summary, this study shows no signiﬁcant change in
patient characteristics over the last 3 decades. Mortality
rates and postoperative complication rates decreased,
and associated cardiac anomalies became the far most
important risk factor for mortality in children born with
oesophageal atresia.
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